Skip to main content
  1. Home
  2. Emerging Tech
  3. Mobile
  4. News

This reusable paper notebook can be erased with 30 seconds in a microwave

Add as a preferred source on Google

Do you burn through notebooks and find yourself constantly having to buy new ones? Check out Rocketbook; it might just be the answer to your problems.

Freshly launched on Indiegogo this week, the notebook is designed to be completely reusable — paper and all. Once you fill up all the pages, the Rocketbook is able to digitize all your notes and store them in the cloud, and then clear all the pages so you can write on them again.

Recommended Videos

How is such a thing possible? Well for starters, the pages of the notebook (which are just regular-ol’ paper, by the way) feature a set of seven different symbols. These symbols can be mapped to different functions, such as saving to Dropbox, Evernote, Google Docs, or even just sending the document to your email inbox. Mark one of the symbols on the page, and when you scan it with Rocketbook’s accompanying smartphone app, a digitized copy of the page will instantly be sent to the cloud storage platform of your choice. Check out the video to see it in action.

 

Now, here’s where it gets crazy: After you’ve scanned, digitized, and saved your notes, you can just pop Rocketbook in the microwave for 30 seconds and it’ll erase all your notes — so long as you use the right type of pen, that is. Rocketbook’s creators encourage users to write in the notebook with Pilot FriXion pens, which use a special kind of thermo-sensitive ink that turns clear when exposed to high temperatures. Rocketbook is designed to be completely microwave safe, so unlike other notebooks,  it won’t melt or catch on fire when you nuke it.

Despite launching just a couple days ago, the project has already fulfilled its $20K funding goal, and has nearly a month to go before the campaign is over. You can lock down a Rocketbook of your own for a pledge of just $25, and assuming everything goes as planned, the company expects to ship the first units in July.

Drew Prindle
Former Senior Editor, Features
Drew Prindle is an award-winning writer, editor, and storyteller who currently serves as Senior Features Editor for Digital…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more